What's Happening?
Vertical Pharmaceuticals, a subsidiary of Alora Pharmaceuticals, has partnered with Medfinder, an AI-enabled medication locating service, to assist patients in finding Relexxii, a medication used to treat ADHD, amid ongoing shortages. This collaboration
allows patients prescribed Relexxii to access Medfinder's pharmacy search service at no cost, helping them locate pharmacies with available inventory or the ability to order the medication. The partnership aims to alleviate the challenges faced by families and care partners in securing ADHD medications, which have been in short supply due to fluctuating pharmacy availability.
Why It's Important?
The shortage of ADHD medications has posed significant challenges for patients and families, disrupting treatment plans and causing stress. By partnering with Medfinder, Vertical Pharmaceuticals is addressing a critical need, ensuring that patients can continue their prescribed treatment without interruption. This initiative not only supports patient health but also highlights the importance of leveraging technology to improve healthcare access. The collaboration underscores the role of pharmaceutical companies in ensuring medication availability and the potential of AI-driven solutions to enhance patient care.
What's Next?
Patients and care partners can utilize Medfinder to identify pharmacies with Relexxii in stock, reducing the time and effort spent searching for the medication. As the partnership progresses, Vertical Pharmaceuticals and Medfinder will continue to monitor the situation and adjust their strategies to ensure effective distribution of Relexxii. Healthcare providers are encouraged to inform patients about this resource, and ongoing communication between pharmacies, patients, and providers will be essential to managing the ADHD medication supply effectively.
